07/06/2011
In the previous Shareholder Bulletin (issued via the ReGen Therapeutics Limited (“RGTL”) website e-mail alert system on 28th April 2011) I explained that an RGTL ‘Update Meeting’ would be held following publication by Alexander David Investments PLC (“ADI”) of its final results for the year ended 31 December 2010.
On 3rd June 2011 ADI published these results and in a mailing on 6th June 2011, ADI announced that it will be holding its Annual General Meeting at 11.00 a.m. on 30th June 2011.
I therefore can announce that a first RGTL ‘Update Meeting’, open to all shareholders and guests, will be held at 11.00 a.m. on Wednesday, 6th July 2011 at the offices of Bird and Bird LLP, 15 Fetter Lane, London, EC4A 1JP.
Please note that this e-mail alert and a copy of it on our website are the only announcements of this ‘Update Meeting’ that will be made although it will appear as a link on the JP Jenkins website. A postal mailing will not be sent to all shareholders in the interest of keeping costs of holding this meeting to a minimum.
Please share this announcement with other shareholders that might not be signed up to receive this e-mail alert via our website and let me know if you are planning to come to the meeting via responding to head.office@regentherapeutics.com . This meeting will only review the RGTL business and not that of ADI. A further Shareholder Bulletin will be issued after the meeting.
Tim Shilton
Chief Executive Officer